Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene.

Trial Profile

Effects of Selective Estrogen Receptor Modulators on Cognitive Aging: Cognition in the Study of Tamoxifen and Raloxifene.

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Raloxifene (Primary) ; Tamoxifen
  • Indications Breast cancer
  • Focus Pharmacodynamics
  • Acronyms Co-STAR
  • Most Recent Events

    • 21 Sep 2009 Endpoints 'California Verbal Learning Test,' 'Cognitive Function Tests,' 'Geriatric Depression Scale' and 'Mini Mental State Examination' have not been met according to Jornal of Clinical Oncology article.
    • 21 Sep 2009 Results published in Journal of Clinical Oncology article.
    • 29 Jul 2008 Results presented at the ICAD 2008. Actual patient number was 1498.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top